ea0042p17 | (1) | Androgens2016
Kallio Heini M L
, Annala Matti
, Brofeldt Anniina
, Hieta Reija
, Kivinummi Kati
, Tammela Teuvo
, Nykter Matti
, Lilja Hans G
, Bova G Steven
, Visakorpi Tapio
Prostate cancer (PC) is the most common malignancy and third most common cause of cancer-related death among men in Europe. Although most PCs grow slowly, 2025% of the patients believed to have organ-confined disease will experience biochemical recurrence already during 5-years of follow-up. The standard treatment against advanced PC is androgen deprivation (ADT). Unfortunately, androgen deprivation treatment eventually fails leading to the emergence of castration resist...